97350 ⎘
Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
SUSTAINED TRANSGENE EXPRESSION OF MODIFIED ERT2 PEPTIDE-SUICIDE PROTEIN FUSION POLYPEPTIDES
#2ERT2 MUTANTS, INDUCIBLE CELL DEATH SYSTEMS, AND USES THEREOF
#3MATERIALS AND METHODS FOR MODIFYING EXPRESSION OF MYOSIN HEAVY CHAIN GENES
#4PROTEOLYTICALLY CLEAVABLE CHIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#5ENGINEERED IMMUNE CELLS WITH DOMINANT SIGNALS
#6PROSTATE CANCER CHIMERIC ANTIGEN RECEPTORS
#7REGULATED SYNTHETIC GENE ACTIVATION SYSTEMS
#8ENGINEERED IMMUNE CELLS WITH RECEPTOR SIGNAL STRENGTH MODULATED BY A HINGE
#9ENGINEERED IMMUNE CELLS WITH RECEPTOR CROSS-TALK
#10METHODS AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASE
#11NOTCH RECEPTORS WITH ZINC FINGER-CONTAINING TRANSCRIPTIONAL EFFECTOR
#12REGULATED SYNTHETIC GENE EXPRESSION SYSTEMS
#13Enhanced immune cells using dual shRNA and composition including the same
#14PROTEOLYTICALLY CLEAVABLE CHIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#15Prostate cancer chimeric antigen receptors
#16CAGED-DEGRON-BASED MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME
#17CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS
#18ENGINEERED IMMUNE CELLS WITH MICRO-CLUSTERS
#19ENGINEERED IMMUNE CELLS WITH MULTIPLEX AND LOCALIZED ACTIVITY
#20Engineered immune cells with receptor cross-talk
#21ENGINEERING IMMUNE CELLS BASED ON ANTIGEN LEVELS
#22Engineered immune cells with receptor signal strength modulated by a hinge
#23Engineered immune cells with dominant signals
#24INHIBITORS OF P-TEFB MEDIATED TRANSCRIPTION
#25Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
#26Enhanced immune cells using dual shRNA and composition including the same
#27Regulated synthetic gene expression systems
#28INTEGRATION OF MESA RECEPTORS AND PROMOTORS TO IMPLEMENT CUSTOMIZED CELLULAR FUNCTION
#29Proteolytically cleavable chimeric polypeptides and methods of use thereof
#30COMPOSITIONS AND METHODS FOR REGULATABLE ANTIBODY EXPRESSION
#31Vectors Conditionally Expressing Protein
#32Methods to create chemically-induced dimerizing protein systems for regulation of cellular events
#33Engineered Dendritic Cells and Uses for the Treatment of Cancer
#34Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and methods for reducing polyQ-mediated toxicity in polyQ diseases
#35UNIVERSAL DONOR CHIMERIC ANTIGEN RECEPTOR CELLS
#36Vectors conditionally expressing protein
#37Steroidal ligands and their use in gene switch modulation
#38Engineered dendritic cells and uses for the treatment of cancer
#39Method for performing homologous recombination in plants
#40PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM
#41Ecdysone receptor-based inducible gene expression system
#42Productivity augmenting protein factor, novel cell lines and uses thereof
#43Engineered Dendritic Cells and Uses for the Treatment of Cancer
#44Pharmacologically induced transgene ablation system
#45Method for controlling the biological activity of a protein in a vertebrate cell
#46SYSTEM FOR PACKAGING HIGH-CAPACITY ADENOVIRUSES
#47SELF-INACTIVATING HELPER ADENOVIRUSES FOR THE PRODUCTION OF HIGH-CAPACTIY RECOMBINANT ADENOVIRUSES
#48Novel Ecdysone Receptor-Based Inducible Gene Expression System
#49Ecdysone receptor-based inducible gene expression system
#50REGULATED TRANSCRIPTION OF TARGETED GENES AND OTHER BIOLOGICAL EVENTS
#51Regulated apoptosis
#52LexA-based chemical-inducible gene expression system for use in transgenic animals
#53Steroidal ligands and their use in gene switch modulation
#54Method for performing homologous recombination in plants
#55Engineered Dendritic Cells and Uses for the Treatment of Cancer
#56Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
#57Regulated transcription of targeted genes and other biological events
#58Methods and compositions for the detection and isolation of ligands
#59Ecdysone receptor-based inducible gene expression system
#60Horming response element binding transregulators
#61Ecdysone receptor-based inducible gene expression system
#62Orthogonal gene switches
#63Peroxisome proliferator-activated receptor
#64Regulated transcription of targeted genes and other biological events
#65Regulated apoptosis